Vanila Singh
Direktor/Vorstandsmitglied bei VIRPAX PHARMACEUTICALS, INC.
Vermögen: - $ am 30.04.2024
Profil
Vanila M.
Singh is an Independent Director at Virpax Pharmaceuticals, Inc., an Associate Professor at Stanford University, and a Member of the American Society of Anesthesiologists.
She was previously an Independent Director at BioDelivery Sciences International, Inc. from 2019 to 2022 and the Chief Medical Officer at the US Department of Health & Human Services from 2017 to 2019.
Singh received her undergraduate degree from the University of California, Berkeley, her graduate degree from Keck School of Medicine of USC, and her doctorate from George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
22.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Vanila Singh
Unternehmen | Position | Beginn |
---|---|---|
VIRPAX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.06.2020 |
American Society of Anesthesiologists
American Society of Anesthesiologists Medical/Nursing ServicesHealth Services American Society of Anesthesiologists provides access to multiple choice questions and corresponding discussions to earn CME credits. The private company is based in Park Ridge, IL, and the CEO of the company is Paul Pomerantz. The company offers top jobs in anesthesiology and publish the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative, critical care, and pain medicine. The company also offers clinical reviews, editorials, podcasts, infographics, and videos. | Corporate Officer/Principal | - |
Stanford University | Corporate Officer/Principal | 01.06.2004 |
Ehemalige bekannte Positionen von Vanila Singh
Unternehmen | Position | Ende |
---|---|---|
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 22.03.2022 |
US Department of Health & Human Services (DC) | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Ausbildung von Vanila Singh
University of California, Berkeley | Undergraduate Degree |
Keck School of Medicine of USC | Graduate Degree |
George Washington University School of Medicine & Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIRPAX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
US Department of Health & Human Services (DC) | Government |
American Society of Anesthesiologists
American Society of Anesthesiologists Medical/Nursing ServicesHealth Services American Society of Anesthesiologists provides access to multiple choice questions and corresponding discussions to earn CME credits. The private company is based in Park Ridge, IL, and the CEO of the company is Paul Pomerantz. The company offers top jobs in anesthesiology and publish the highest-impact, peer-reviewed medical journal that publishes trusted evidence that transforms the practice of perioperative, critical care, and pain medicine. The company also offers clinical reviews, editorials, podcasts, infographics, and videos. | Health Services |